Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Asthma

Free Subscription 13.07.2026 1 Allergy 1 Am J Respir Crit Care Med 1 Ann Allergy Asthma Immunol 1 Ann Intern Med 2 Chest 1 Clin Exp Allergy 1 Eur Respir J 1 J Allergy Clin Immunol 7 J Asthma 1 J Immunol 1 JAMA 1 Pediatr Pulmonol 1 Respir Med 1 Respir Res 2 Respirology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. YANG F, Seo S, Hasegawa T, Bloom CI, et al
   Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma.
   Allergy. 2026 Jul 9. doi: 10.1111/all.70436.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

2. MASSENET T, Stefanuto PH, Peltrini Omega, Cordell Omega, et al
   Eosinophil-derived breath biomarkers and response to anti-IL-5/5R biologics in severe asthma.
   Am J Respir Crit Care Med. 2026 Jul 8:aamag329. doi: 10.1093.
   PubMed        
   
   

   
   Ann Allergy Asthma Immunol

3. GROGAN CE, Elliott MR, Marshall GD Jr
   New Pharmaceutical Options for Patients with Allergic and Asthma-Related Diseases: Balancing Effectiveness and Safety in Selection of Specific Therapies.
   Ann Allergy Asthma Immunol. 2026 Jul 8:S1081-1206(26)00335.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. HOO GWS
   In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at
   Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02405.
   PubMed         Abstract available
   
   

   
   Chest

5. RIVARD R, Mailhot-Larouche S, Borg C, Pujan P, et al
   Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleurkin-5 Biologics.
   Chest. 2026;170:e1-e4.
   PubMed         Abstract available
   
   
6. TASHKIN DP
   Does Inhaled Marijuana Use Have an Adverse Effect On Asthma?: An Incomplete Answer.
   Chest. 2026;170:3-5.
   PubMed        
   
   

   
   Clin Exp Allergy

7. LEE Y, Kim H, Jo H, Lee S, et al
   Maternal Diabetes and Subsequent Risk of Asthma and Atopic Dermatitis in Offspring: A Binational Birth Cohort Study in South Korea and Japan.
   Clin Exp Allergy. 2026 Jul 5. doi: 10.1111/cea.70385.
   PubMed        
   
   

   
   Eur Respir J

8. BACHARIER LB, Busse WW, Jackson DJ, Katial RK, et al
   Critical flaws in: "Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study".
   Eur Respir J. 2026;68:2501565.
   PubMed         Abstract available
   
   

   
   J Allergy Clin Immunol

9. ZHONG X, Salamone IM, Nobrega MA, He X, et al
   Post-GWAS Variant-to-Function Challenges in Asthma Research.
   J Allergy Clin Immunol. 2026 Jul 9:S0091-6749(26)00483.
   PubMed         Abstract available
   
   

   
   J Asthma

10. BOGHALE S, Hadj Fredj S, Amri Y, Sidatt M, et al
    IL-10 promoter polymorphisms (-1082G > A, -819C > T and - 592 C > A) and pediatric asthma susceptibility in a Mauritanian population.
    J Asthma. 2026 Jul 9:1-12. doi: 10.1080/02770903.2026.2696576.
    PubMed         Abstract available
    
    
11. BULT L, van Deelen S, van Daalen MS, van Deurzen BWA, et al
    Impact of biologic therapy on ICS/LABA adherence in severe asthma: assessment of inhaler therapy adherence remains imperative.
    J Asthma. 2026 Jul 7:1-8. doi: 10.1080/02770903.2026.2696582.
    PubMed         Abstract available
    
    
12. MUNIVE AA, Fernandez Corzo MA, Rendon A, Cavalet Blanco D, et al
    Long-term efficacy and safety of dupilumab in patients enrolled from Latin American centers from the open-label extension LIBERTY ASTHMA TRAVERSE study.
    J Asthma. 2026 Jul 7:1-16. doi: 10.1080/02770903.2026.2696570.
    PubMed         Abstract available
    
    
13. OZDEL OZTURK B, Sengul Emeksiz Z, Celebi Sozener Z, Yilmaz O, et al
    Perceptions, Attitudes, and Real-World Use of FENO in Allergy and Asthma Practice: Results of a National Survey from Turkiye.
    J Asthma. 2026 Jul 8:1-16. doi: 10.1080/02770903.2026.2701397.
    PubMed         Abstract available
    
    
14. GU L, Li J, Yin Z, Zhang D, et al
    Proton Pump Inhibitor Target Genes and Asthma Susceptibility: A Mendelian Randomization Study with Identification of IL-2 as a Potential Mediator.
    J Asthma. 2026 Jul 8:1-17. doi: 10.1080/02770903.2026.2700538.
    PubMed         Abstract available
    
    
15. CHEN LY, Hua HB, Chen YY
    Negative association between asthma and tuberculosis: The mediating effect of albumin.
    J Asthma. 2026 Jul 10:1-13. doi: 10.1080/02770903.2026.2701401.
    PubMed         Abstract available
    
    
16. ZHAO K, Dong R, BaCo K, Wei W, et al
    Association between Dietary Intake of Live Microbes and Asthma Risk in Children and Adolescents Aged 6-15 Years: A Cross-sectional analysis.
    J Asthma. 2026 Jul 10:1-14. doi: 10.1080/02770903.2026.2701395.
    PubMed         Abstract available
    
    

    
    J Immunol

17. KAUR S, Lin YP, Nakano H, Brown P, et al
    The scaffolding protein AKAP79/150 shapes innate immune responses to allergen.
    J Immunol. 2026;215:vkag115.
    PubMed         Abstract available
    
    

    
    JAMA

18. ANDERER S
    Approval of Respiratory Biologics Linked to Decline in Asthma Exacerbations.
    JAMA. 2026 Jul 10. doi: 10.1001/jama.2026.9473.
    PubMed        
    
    

    
    Pediatr Pulmonol

19. FARIA RJ, Bazoni PS, Santos JBRD, Silva ETD, et al
    Efficacy and Safety of Biologic Therapies for Uncontrolled Asthma: An Overview of Systematic Reviews.
    Pediatr Pulmonol. 2026;61:e71727.
    PubMed         Abstract available
    
    

    
    Respir Med

20. PATEL V, Khera N, Singh G, Khalid Ansari MA, et al
    ASTHMA AT THE CROSSROADS: FROM ANTI-TNF-alpha SETBACKS TO NEXT-GENERATION BIOLOGICS TARGETING TYPE 1 AND TYPE 2 INFLAMMATION.
    Respir Med. 2026 Jul 9:109033. doi: 10.1016/j.rmed.2026.109033.
    PubMed         Abstract available
    
    

    
    Respir Res

21. PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
    Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma.
    Respir Res. 2026;27:276.
    PubMed         Abstract available
    
    

    
    Respirology

22. O'BRIEN H, Franciosi AN
    Not All Flares Are Equal: Stratifying Risk During Asthma/COPD Overlap Exacerbations.
    Respirology. 2026 Jul 8. doi: 10.1002/resp.70287.
    PubMed        
    
    
23. PRICE CC, Koh MS, Ko FW, Bardin PG, et al
    Enhancing Asthma Management in Emergency Departments: New Approaches Are Vital for Effective Care.
    Respirology. 2026 Jul 6. doi: 10.1002/resp.70284.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum